Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients

Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients

Background: The biomarkers of immune checkpoint inhibitors (ICIs) efficacy and safety are still urgently needed. As cytokines are easily detected and monitored in circulation, they could be used as potential predictors of response and immune-related adverse events (irAEs) for ICIs therapy. Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales: Katarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, Irina Besu Žižak, Jelena Milovanović, Suzana Matković, Vladimir Jurišić
Formato: Artículo
Lenguaje:English
Publicado: Elsevier 2023-12-01
Colección:Translational Oncology
Materias:
Metastatic melanoma patients
BRAF wild type
Pembrolizumab
Cytokines
Monitoring
Outcome predictors
Acceso en línea:http://www.sciencedirect.com/science/article/pii/S1936523323001857

Ejemplares similares

Ejemplares similares